Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Beuschlein

Showing results (441-450 of 445) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 445 results.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 1, 2024
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paragangliomaMaría Monteagudo, Bruna Calsina, Milton E Salazar-Hidalgo, et al.
The Lancet. Diabetes & Endocrinology|July 27, 2020
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Angela E Taylor, Vasileios Chortis, et al.
Nature Communications|February 28, 2023
Genomic and immune landscape Of metastatic pheochromocytoma and paragangliomaBruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
MAX mutations cause hereditary and sporadic pheochromocytoma and paragangliomaNelly Burnichon, Alberto Cascón, Francesca Schiavi, et al.
Pageof 45

Showing results (441-450 of 445) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 445 results.
European Journal of Endocrinology|November 9, 2020
ENSAT registry-based randomized clinical trials for adrenocortical carcinomaJoakim Crona, Eric Baudin, Massimo Terzolo, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|September 1, 2024
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paragangliomaMaría Monteagudo, Bruna Calsina, Milton E Salazar-Hidalgo, et al.
The Lancet. Diabetes & Endocrinology|July 27, 2020
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation studyIrina Bancos, Angela E Taylor, Vasileios Chortis, et al.
Nature Communications|February 28, 2023
Genomic and immune landscape Of metastatic pheochromocytoma and paragangliomaBruna Calsina, Elena Piñeiro-Yáñez, Ángel M Martínez-Montes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2012
MAX mutations cause hereditary and sporadic pheochromocytoma and paragangliomaNelly Burnichon, Alberto Cascón, Francesca Schiavi, et al.
Pageof 45